311 related articles for article (PubMed ID: 25526608)
1. Interventions for melanoma in situ, including lentigo maligna.
Tzellos T; Kyrgidis A; Mocellin S; Chan AW; Pilati P; Apalla Z
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010308. PubMed ID: 25526608
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
4. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
Erickson C; Miller SJ
Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
[TBL] [Abstract][Full Text] [Related]
6. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Lawrie TA; Nordin A; Chakrabarti M; Bryant A; Kaushik S; Pepas L
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011837. PubMed ID: 26728940
[TBL] [Abstract][Full Text] [Related]
7. Medical interventions for high-grade vulval intraepithelial neoplasia.
Pepas L; Kaushik S; Nordin A; Bryant A; Lawrie TA
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007924. PubMed ID: 26284429
[TBL] [Abstract][Full Text] [Related]
8. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
9. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
11. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
12. Treatment of lentigo maligna with imiquimod before staged excision.
Cotter MA; McKenna JK; Bowen GM
Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
14. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
15. Interventions for mycosis fungoides.
Valipour A; Jäger M; Wu P; Schmitt J; Bunch C; Weberschock T
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008946. PubMed ID: 32632956
[TBL] [Abstract][Full Text] [Related]
16. Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna.
Robinson M; Primiero C; Guitera P; Hong A; Scolyer RA; Stretch JR; Strutton G; Thompson JF; Soyer HP
Dermatology; 2020; 236(2):111-116. PubMed ID: 31639788
[TBL] [Abstract][Full Text] [Related]
17. Interventions for cutaneous molluscum contagiosum.
van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Reducing Final Surgical Defect Sizes in the Treatment of Lentigo Maligna.
Sampson BP; Bowen GM
Dermatol Surg; 2020 Apr; 46(4):537-545. PubMed ID: 31464705
[TBL] [Abstract][Full Text] [Related]
20. Topical imiquimod immunotherapy in the management of lentigo maligna.
Powell AM; Russell-Jones R; Barlow RJ
Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]